Non-invasive positive pressure ventilation for acute asthma in children.
BACKGROUND
Asthma is one of the most common reasons for hospital admission among children and constitutes a significant economic burden. Use of non-invasive positive pressure ventilation (NPPV) in the care of children with acute asthma has increased even though evidence supporting the intervention has been considered weak and clinical guidelines do not recommend the intervention. NPPV might be an effective intervention for acute asthma, but no systematic review has been conducted to assess the effects of NPPV as an add-on therapy to usual care in children with acute asthma.


OBJECTIVE
To assess the benefits and harms of NPPV as an add-on therapy to usual care (e.g. bronchodilators and corticosteroids) in children with acute asthma.


METHODS
We identified trials from the Cochrane Airways Group Specialised Register (CAGR). The Register contains trial reports identified through systematic searches of bibliographic databases, including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, CINAHL, AMED and PsycINFO, and by handsearching of respiratory journals and meeting abstracts. We also conducted a search of ClinicalTrials.gov (www.ClinicalTrials.gov) and the WHO trials portal (www.who.int/ictrp/en/). We searched all databases from their inception to February 2016, with no restriction on language of publication.


METHODS
We included randomised clinical trials (RCTs) assessing NPPV as add-on therapy to usual care versus usual care for children (age < 18 years) hospitalised for an acute asthma attack.


METHODS
Two review authors independently screened titles and abstracts. We retrieved all relevant full-text study reports, independently screened the full text, identified trials for inclusion and identified and recorded reasons for exclusion of ineligible trials. We resolved disagreements through discussion or, if required, consulted a third review author. We recorded the selection process in sufficient detail to complete a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) flow diagram and 'Characteristics of excluded studies' table. We identified the risk of bias of included studies to reduce the risk of systematic error. We contacted relevant study authors when data were missing.


RESULTS
We included two RCTs that randomised 20 participants to NPPV and 20 participants to control. We assessed both studies as having high risk of bias; both trials assessed effects of bilateral positive airway pressure (BiPAP). Neither trial used continuous positive airway pressure (CPAP). Controls received standard care. Investigators reported no deaths and no serious adverse events (Grades of Recommendation, Assessment, Development and Evaluation (GRADE): very low quality of evidence due to serious risk of bias and serious imprecision of results). Both trials showed a statistically significant reduction in symptom score. One trial did not report a standard deviation (SD), but by using an estimated SD, we found a statistically significantly reduced asthma symptom score (mean difference (MD) -2.50, 95% confidence interval (CI) -4.70 to -0.30, P = 0.03, 19 participants, GRADE: very low quality of evidence). In the other trial, NPPV was associated with a lower total symptom score (5.6 vs 1.9, 16 participants, very low quality of evidence) before cross-over, but investigators did not report an SD, nor could it be estimated from the first phase of the trial, before the cross-over. These gains could be clinically relevant, as a reduction of three or more points in symptom score is considered a clinically meaningful change. Researchers documented five dropouts (12.5%), four of which were due to intolerance to NPPV, and one to respiratory failure requiring intubation. Owing to insufficient reporting in the latter trial and use of different scoring systems, it was not possible to conduct a meta-analysis nor a Trial Sequential Analysis.


CONCLUSIONS
Current evidence does not permit confirmation or rejection of the effects of NPPV for acute asthma in children. Large RCTs with low risk of bias are warranted.
Pediatric Department, Holbaek Sygehus, Smedelundsgade 60, Holbaek, Denmark, 4300.
Steven Kwasi
SK
Korang
Joshua
J
Feinberg
Jørn
J
Wetterslev
Janus C
JC
Jakobsen
Biometrics. 1994 Dec;50(4):1088-101
7786990
Ann Intern Med. 2012 Sep 18;157(6):429-38
22945832
Clin Epidemiol. 2010 Aug 09;2:57-66
20865104
Int J Tuberc Lung Dis. 2014 Nov;18(11):1269-78
25299857
Control Clin Trials. 1986 Sep;7(3):177-88
3802833
Cochrane Database Syst Rev. 2012 Dec 12;12:CD004360
23235608
Allergy. 2004 May;59(5):469-78
15080825
Intensive Care Med. 1999 Jun;25(6):567-73
10416907
Stat Med. 2002 Jun 15;21(11):1539-58
12111919
Am J Med. 1993 Mar;94(3):281-8
8452152
Scand J Respir Dis. 1979 Oct;60(5):260-6
392747
N Engl J Med. 1979 Aug 30;301(9):453-9
460363
Thorax. 1982 Aug;37(8):612-6
6758179
Respir Physiol Neurobiol. 2013 Aug 1;188(1):66-70
23681081
J Pediatr. 2000 Dec;137(6):762-8
11113831
Eur Respir J. 1996 May;9(5):952-9
8793457
JAMA. 2002 Aug 28;288(8):932-5
12190351
Paediatr Respir Rev. 2005 Mar;6(1):52-60
15698817
Intern Med. 2008;47(6):493-501
18344635
J Clin Epidemiol. 2008 Jan;61(1):64-75
18083463
Curr Opin Crit Care. 2012 Feb;18(1):48-53
22186215
J Asthma. 2015 Mar;52(2):220-6
25144550
Stat Med. 1987 Apr-May;6(3):341-50
3616287
Rev Mal Respir. 1999 Apr;16(2):181-7
10339761
Am J Respir Crit Care Med. 2012 Feb 1;185(3):281-5
21960534
Int J Epidemiol. 2002 Dec;31(6):1098-102
12540698
Pediatr Crit Care Med. 2012 Jul;13(4):407-14
22067984
Pediatr Pulmonol. 2011 Oct;46(10):949-55
21520437
Am J Epidemiol. 2006 Mar 15;163(6):493-501
16443796
Am J Respir Crit Care Med. 2009 Feb 1;179(3):179-85
19029000
Chest. 2006 Jul;130(1 Suppl):4S-12S
16840363
BMJ. 2016 Feb 08;352:i493
26858277
BMC Pulm Med. 2009 May 19;9:24
19454036
Acad Emerg Med. 2014 Aug;21(8):872-8
25176153
Allergy. 2012 Aug;67(8):976-97
22702533
J Clin Pharmacol. 1982 May-Jun;22(5-6):231-5
7050188
Eur J Health Econ. 2016 Mar;17(2):195-201
25716136
Immunol Lett. 2007 Oct 31;113(1):6-18
17765979
NCHS Data Brief. 2012 May;(94):1-8
22617340
Am J Respir Crit Care Med. 1994 Oct;150(4):896-903
7921460
Curr Opin Pulm Med. 2014 Jan;20(1):8-16
24240439
J Pediatr. 2008 Apr;152(4):476-80, 480.e1
18346499
Eur J Respir Dis Suppl. 1982;119:97-100
7047190
Pediatr Crit Care Med. 2004 Jul;5(4):337-42
15215002
Anesth Analg. 2005 Sep;101(3):843-850
16116002
Stat Med. 2006 Oct 30;25(20):3443-57
16345038
J Bras Pneumol. 2015 Jan-Feb;41(1):16-22
25750670
J Pediatr. 2013 Oct;163(4):1127-33.e3
23769497
Crit Care Med. 2005 Jul;33(7):1519-28
16003057
Nature. 2008 Jul 24;454(7203):445-54
18650915
Respir Med. 1995 Feb;89(2):121-8
7708996
Ann Am Thorac Soc. 2016 Nov;13(11):1940-1950
27398992
Respiration. 1987;52(3):157-62
3326082
Pediatr Pulmonol. 2001 Jun;31(6):405-11
11389571
Respir Care. 2009 Jan;54(1):116-26
19111111
Chest. 1991 Aug;100(2):317-21
1864100
Vital Health Stat 10. 2013 Dec;(258):1-81
24784481
Pediatr Crit Care Med. 2012 Jul;13(4):393-8
22067982
N Engl J Med. 1995 Feb 9;332(6):345-50
7823995
BMC Med Res Methodol. 2014 Nov 21;14:120
25416419
BMJ. 1997 Sep 13;315(7109):629-34
9310563
Clin Rev Allergy Immunol. 2015 Feb;48(1):66-83
24488329
Intensive Care Med. 1997 Oct;23(10):1024-32
9407237
Rev Bras Ter Intensiva. 2015 Oct-Dec;27(4):390-6
26761478
J Asthma. 2009 May;46(4):356-61
19484669
Pediatr Crit Care Med. 2002 Apr;3(2):181-184
12780991
Ir Med J. 1999 Sep-Oct;92(6):401-3
10598422
Crit Care Clin. 2013 Apr;29(2):153-66
23537669
Emerg Med J. 2003 Nov;20(6):531-4
14623840
Curr Opin Allergy Clin Immunol. 2013 Apr;13(2):193-202
23407123
J Am Board Fam Med. 2014 Jul-Aug;27(4):538-48
25002008
Am Rev Respir Dis. 1982 Jul;126(1):166-70
7046541
Respir Care. 2005 Jan;50(1):110-23; discussion 123-4
15636649
Int J Epidemiol. 2009 Feb;38(1):276-86
18824467
Am J Respir Crit Care Med. 2014 May 1;189(9):1031-6
24787065
BMJ. 2008 Mar 15;336(7644):601-5
18316340
Chest. 1993 Oct;104(4):1108-13
8404176
Am J Emerg Med. 2007 Jan;25(1):6-9
17157675
J Clin Epidemiol. 2008 Aug;61(8):763-9
18411040
Curr Allergy Asthma Rep. 2014 Oct;14(10):465
25149167
Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033
23235689
Appl Cardiopulm Pathophysiol. 1991;4(1):79-83
10147542
Ann Intern Med. 2001 Dec 4;135(11):982-9
11730399
Front Physiol. 2012 Dec 10;3:460
23233839
Br J Dis Chest. 1982 Jan;76(1):69-74
7037036
Thorax. 1997 Feb;52(2):171-5
9059480
Respir Care. 2010 May;55(5):536-43
20420722
Lancet. 1998 Aug 22;352(9128):609-13
9746022
Int J Epidemiol. 2009 Feb;38(1):287-98
18824466
Cochrane Database Syst Rev. 2016 Sep 30;9:CD012067
27687114
Intensive Care Med. 2007 Jan;33(1):120-7
17111110
BMC Med Res Methodol. 2009 Dec 30;9:86
20042080
Eur Respir Rev. 2012 Sep 1;21(125):175-85
22941882
Chest. 2003 Apr;123(4):1018-25
12684289
Am Rev Respir Dis. 1982 Nov;126(5):812-7
6216839
Am Rev Respir Dis. 1993 Apr;147(4):845-9
8466118
J Clin Epidemiol. 2009 Oct;62(10):1006-12
19631508
Early Hum Dev. 2013 Oct;89 Suppl 3:S25-31
23958409
Br J Dis Chest. 1983 Jul;77(3):255-61
6351888
Intensive Care Med. 2011 Aug;37(8):1338-43
21567114
BMJ. 2003 Sep 6;327(7414):557-60
12958120